Matches in Nanopublications for { <http://www.tkuhn.ch/bel2nanopub/RAel_Xv7Ab3UlpI2d0-4iY1Ur9vgInJ6KNgwNPadc55HY#_2> ?p ?o ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- _2 value "Chymostatin (5-10 nmol(-1) site(-1) day(-1)) reduced granuloma-associated angiogenesis by 57.3 and 70.0%. RT-PCR analysis showed that rMCP-5 mRNA amounts were significantly reduced by rMCP-5 AS-ODN (1.25-2.5-5.0 nmol site(-1)) by 69.5, 72.5 and 81.8%. In parallel experiments, rMCP-5 AS-ODN (1.25, 2.5, 5.0 nmol site(-1)) strongly reduced granuloma weight (26.1, 45.0 and 56.3%) and haemoglobin content (22.2, 50.4, 62.03%), suggesting that the observed effect is mediated through an antisense mechanism. In conclusion, these data suggest that: (i) inhibition of mast cell mediators release may represent a novel strategy to modulate angiogenesis; (ii) among the chymase family, rMCP-5 is a key promoter of angiogenesis in the rat." provenance.
- _2 wasQuotedFrom 15723097 provenance.